SM

Shrinath Munnilal Kanojiya

Active Director Designated Partner DIN 10005299
DIN 10005299 First appointment May 2022 Primary industry Healthcare
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since May 2022
Shareholding value β€’β€’β€’β€’ Premium profile

About Shrinath Munnilal Kanojiya

Data last updated:

Shrinath Munnilal Kanojiya is a Designated Partner at Jeevanam Hospital & Research Centre Llp (since 2022). The company operates in Healthcare.

DIN 10005299
Primary Designation Designated Partner
Industry Healthcare
First Appointment 31 May 2022
Oldest Company Age 4 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Designated Partner31 May 20222022Active

Board colleagues of Shrinath Munnilal Kanojiya

Directorship timeline

Open interactive timeline →
Jeevanam Hospital & Research Centre Llp
Premium access

Shareholding and investment profile for Shrinath Munnilal Kanojiya

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Shrinath Munnilal Kanojiya

Shrinath Munnilal Kanojiya currently holds 1 directorship: Jeevanam Hospital & Research Centre Llp (Designated Partner, since 31 May 2022).

Shrinath Munnilal Kanojiya was first appointed on 31 May 2022 as Designated Partner at Jeevanam Hospital & Research Centre Llp.

The current boards of Shrinath Munnilal Kanojiya's companies include Abhishek Sudhakar Shetty (Jeevanam Hospital & Research Centre Llp), Munivenkataramana Mucheli (Jeevanam Hospital & Research Centre Llp).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available